COVID-19

June 14, 2022
ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir,[...]

May 7, 2020

May 6, 2020

May 6, 2020

May 6, 2020

May 4, 2020
Explore more topics
Sign up

Mayo Clinic Connect
An online patient support community